BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
|Open|| Long (1Y)
Edelweiss Maintains 'Buy' On Dr Reddy's Laboratories
According to Edelweiss, the company's US performance appears to be stabilising. A promising complex generics pipeline, strong earnings revival and compelling valuations render Dr Reddy's as a prime re-rating candidate, the brokerage adds.